Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

Clinical trial NCT00374699 · COMPLETED

Trial details

NCT number: NCT00374699
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-Cell Lymphomas Non-Hodgkin Lymphoma

Start date: 2006-04-01
Primary completion: 2009-09-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.